Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Immunofoco Announces the Dual Approval of IND Applications by the U.S. FDA and China CDE for the First EpCAM CAR-T Targeted at Advanced Solid Tumors 2024-02-23 12:51
Jolly Good Revolutionizes Healthcare with Immersive Service for Apple Vision Pro, Premiering at SXSW 2024 2024-02-23 02:00
CATUG and Crystal Bio Establish Strategic Partnership, Launching "CATUG-Crystal" Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services 2024-02-22 21:00
VOCIC Presents its Latest Products at Arab Health 2024 in Dubai 2024-02-21 22:20
Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology 2024-02-21 22:00
WuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics 2024-02-21 18:00
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE 2024-02-21 16:16
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets 2024-02-21 11:56
Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology 2024-02-20 22:30
FDA Grants Orphan Drug Designation to 9MW3011 2024-02-20 22:00
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711 2024-02-20 22:00
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma 2024-02-20 21:00
Origin Agritech Regains Compliance with Nasdaq Listing Standards 2024-02-20 20:00
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price 2024-02-20 20:00
Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818 in Crohn's Disease at the 19th Congress of ECCO (IND Application for Phase II in Progress) 2024-02-20 20:00
Neurophth Announces Completion of Patient Enrollment for Opvika® Phase I/II Clinical Trial in the U.S. 2024-02-19 19:30
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor 2024-02-18 20:50
China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI 2024-02-17 21:30
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC 2024-02-16 22:03
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology 2024-02-15 11:37
1 47 48 49 50 51 812